Neurotar attends Bio-Europe Spring 2011 Partnering Conference in Milan on March 14-16 and presents among the Next Generation companies

On December 3, 2010, the Finnish Funding Agency for Technology and Innovation (TEKES) awards funding for Neurotar’s R&D project.

The Finnish Funding Agency for Technology and Innovation announced its decision to fund the first phase of Neurotar’s Research & Development project aimed at developing Neurotar’s services in the areas of CNS and dermatology. The title of the project, “Beyond the Surface”, points toward our unique capability of seeing details where others see a blurred or incomplete picture. In metaphorical sense, it is meant to describe our close involvement with the Clients’ needs. Neurotar was awarded the maximum amount available under the current application, which we consider a sign of trust in our potential and the seal of approval of our work up-to-date.